Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.59 |
| ▸ | RAB9A | P51151 | 2/20 | 0.47 |
| ▸ | KDM4A | O75164 | 2/20 | 0.47 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.47 |
| ▸ | HIF1AN | Q9NWT6 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.45 |
| ▸ | PIM1 | P11309 | 1/20 | 0.45 |
| ▸ | IGFBP3 | P17936 | 1/20 | 0.43 |
| ▸ | PARP1 | P09874 | 2/20 | 0.43 |
| ▸ | TNKS | O95271 | 1/20 | 0.43 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Xanthurenate SCHEMBL29911018 | 1.00 | KDM4E (0.59) | KDM4EKMT2ARAB9AKDM4AEGLN1 | |
| Xanthurenate SCHEMBL29394132 | 1.00 | KDM4E (0.59) | KDM4EKMT2ARAB9AKDM4AEGLN1 | |
| SCHEMBL6080750 | 0.85 | KDM4E (0.46) | KDM4EKMT2ARAB9AKDM4AEGLN1 | |
| SCHEMBL6080058 | 0.85 | KDM4E (0.46) | KDM4EKMT2ARAB9AALOX15TDP1 | |
| SCHEMBL6079537 | 0.85 | KDM4E (0.54) | KDM4EKMT2ARAB9AKDM4AEGLN1 | |
| SCHEMBL2909426 | 0.85 | KDM4E (0.49) | KDM4EKMT2ARAB9AALOX15TDP1 | |
| SCHEMBL3333164 | 0.85 | GRM2 (0.48) | KDM4EKMT2ARAB9AALOX15TDP1 | |
| SCHEMBL6080102 | 0.85 | KDM4E (0.56) | KDM4EKMT2ARAB9AKDM4AEGLN1 | |
| SCHEMBL6594758 | 0.85 | KDM4E (0.46) | KDM4EKMT2ARAB9AKDM4AEGLN1 | |
| SCHEMBL5211310 | 0.84 | PIM1 (0.60) | KDM4EKMT2ARAB9AKDM4AEGLN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1533 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260053887-A1 | Methods and Kits to Prevent And/Or Treat Cardiac Disorders | UNIV IOWA RES FOUND (US) | 2026-02-26 | — | — | US | claimed |
| US-20250367269-A1 | KYNURENINE AMINOTRANSFERASE AND PRODUCTS THEREOF FOR THE TREATMENT OF ARTHRITIC DISEASES | INSTITUT NATIONAL DE RECH POUR LAGRICULTURE LALIMENTATION ET L’ENVIRONNEMENT (FR) | 2025-12-04 | — | — | US | claimed |
| EP-4648788-A1 | LIPID BINDING PROTEIN MOLECULE THERAPY | Abionyx Pharma SA (FR) | 2025-11-19 | — | — | EP | claimed |
| EP-4622648-A1 | SELECTION OF PATIENTS FOR THE TREATMENT OF FADS1-MEDIATED DISEASES OR DISORDERS USING FADS-1 INHIBITORS | Amgen Inc. (US) | 2025-10-01 | — | — | EP | claimed |
| US-20250275954-A1 | USE OF KYNURENIC ACID RESISTING HYPERURICEMIA AND STRUCTURAL ANALOG THEREOF IN PREPARATION OF XOD INHIBITOR | UNIV JIMEI (CN) | 2025-09-04 | — | — | US | claimed |
| US-20250255792-A1 | Methods of Using a Small Molecule Chemical Compound to Reduce the Appearance of Rhytids and Wrinkles | BIRCHBIOMED INC. (CA) | 2025-08-14 | — | — | US | claimed |
| EP-4572737-A1 | METHODS OF USING A SMALL MOLECULE CHEMICAL COMPOUND TO REDUCE THE APPEARANCE OF RHYTIDS AND WRINKLES | Birchbiomed Inc. (CA) | 2025-06-25 | — | — | EP | claimed |
| CN-120195409-A | Composition for diagnosing sepsis and medicament for sepsis preventive treatment | 北京大学第三医院（北京大学第三临床医学院） | 2025-06-24 | — | — | CN | claimed |
| WO-2025107568-A1 | USE OF KYNURENIC ACID IN RESISTING HYPERURICEMIA AND STRUCTURAL ANALOG THEREOF IN PREPARING XOD INHIBITOR | 集美大学 | 2025-05-30 | — | — | WO | claimed |
| US-20250172571-A1 | Biosignatures for Fatigue Syndromes | LABORATORIUM M NUYTINCK (BE) | 2025-05-29 | — | — | US | claimed |
| EP-0653680-A2 | Photosensitive composition, photosensitive material and image forming method | CANON KABUSHIKI KAISHA (JP) | 1995-05-17 | — | — | EP | claimed |
| WO-1995003815-A1 | ANTIBODIES SPECIFIC TO QUINOLINIC ACID | GEORGETOWN UNIVERSITY (US) | 1995-02-09 | — | — | WO | claimed |
| WO-1995002699-A1 | ANALOGUES OF REPORTER GROUPS AS BACKGROUNG REDUCERS IN HYBRIDIZATION ASSAYS | APROGENEX, INC. (US) | 1995-01-26 | — | — | WO | claimed |
| EP-0168277-B2 | POLY(ORTHOESTER)POLYMERS CONTAINING PENDANT ACID FUNCTIONALITIES AND LABILE BACKBONE BONDS | Merck & Co., Inc. (US) | 1992-12-30 | — | — | EP | claimed |
| EP-0168277-B1 | Poly(orthoester)polymers containing pendant acid functionalities and labile backbone bonds | MERCK & CO. INC. (US) | 1990-08-01 | — | — | EP | claimed |
| US-4765973-A | Polymers containing pendant acid functionalities and labile backbone bonds | MERCK & CO., INC. (US) | 1988-08-23 | — | — | US | claimed |
| US-4639366-A | Polymers containing pendant acid functionalities and labile backbone bonds | MERCK & CO., INC. (US) | 1987-01-27 | — | — | US | claimed |
| US-4620850-A | HYDROXYBENZOLFURANONE | WELLA AKTIENGESELLSCHAFT (DE) | 1986-11-04 | — | — | US | claimed |
| EP-0168277-A1 | Poly(orthoester)polymers containing pendant acid functionalities and labile backbone bonds | MERCK & CO. INC. (US) | 1986-01-15 | — | — | EP | claimed |
| EP-0026474-B1 | COMPOSITION AND PROCESS FOR OXIDATIVE DYEING OF HAIR | Wella Aktiengesellschaft (DE) | 1983-06-08 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250275954-A1 | USE OF KYNURENIC ACID RESISTING HYPERURICEMIA AND STRUCTURAL ANALOG THEREOF IN PREPARATION OF XOD INHIBITOR | XDH, DAO, KMO | KDM4E 1180/4885KMT2A 709/4885RAB9A 3688/4885 |
| US-20250367269-A1 | KYNURENINE AMINOTRANSFERASE AND PRODUCTS THEREOF FOR THE TREATMENT OF ARTHRITIC DISEASES | AADAT, KYNU, KMO | KDM4E 1825/4885KMT2A 767/4885RAB9A 3199/4885 |
| US-20260053887-A1 | Methods and Kits to Prevent And/Or Treat Cardiac Disorders | KYNU, AADAT, TPH1 | KDM4E 2313/4885KMT2A 1843/4885RAB9A 1482/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.